Antimicrobial Resistance & Stewardship

A failure of the antibiotics market is hampering vital innovation in this field. Researchers from the Toulouse School of Economics (TSE) propose a new mechanism for compensating innovation, taking the form of a voucher that would be transferable.

Since 2019, bioMérieux has partnered with the Fleming Fund to provide high medical value diagnostic solutions, innovative data analytics tools and antimicrobial susceptibility testing in 15 countries located in the Africa and Asia Pacific regions.

While the majority of major drug companies have been scaling back or cutting antibiotic research, diagnostics and advanced data analytics can help preserve existing treatments for patients.

Further investment in and use of technologies such as reporting software can mean that antimicrobial stewardship staff no longer spend weeks working from spreadsheets and can deliver the all-important antibiograms sooner.

With optimized sepsis management protocols and guidance from antimicrobial stewardship programs, it is possible to combat antimicrobial resistance alongside sepsis.